ID,Gene_name,Variant_effect,ELMIdentifier,startstop,comm,Accession,FunctionalSiteName,Description,Regex,Probability,#Instances,#Instances_in_PDB
rs559931747,SCN2A,missense,LIG_WD40_WDR5_VDV_2,1145-1152,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs559931747,SCN2A,missense,LIG_WD40_WDR5_VDV_2,1147-1152,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs572075052,CEP290,missense,LIG_WD40_WDR5_VDV_2,1167-1171,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs549579496,LRP5,missense,LIG_WD40_WDR5_VDV_2,185-192,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs549579496,LRP5,missense,LIG_WD40_WDR5_VDV_2,191-194,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544017143,DSP,missense,LIG_WD40_WDR5_VDV_2,501-508,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs137852785,PDX1,missense,LIG_WD40_WDR5_VDV_2,14-19,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs137852785,PDX1,missense,LIG_WD40_WDR5_VDV_2,16-19,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201496378,BBS4,missense,LIG_WD40_WDR5_VDV_2,212-217,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141947938,CHD7,missense,LIG_WD40_WDR5_VDV_2,738-745,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141947938,CHD7,missense,LIG_WD40_WDR5_VDV_2,739-745,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141947938,CHD7,missense,LIG_WD40_WDR5_VDV_2,740-745,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141947938,CHD7,missense,LIG_WD40_WDR5_VDV_2,741-745,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs141947938,CHD7,missense,LIG_WD40_WDR5_VDV_2,742-745,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs549381482,PROK2,missense,LIG_WD40_WDR5_VDV_2,45-50,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199950526,ABCC6,missense,LIG_WD40_WDR5_VDV_2,1427-1434,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199950526,ABCC6,missense,LIG_WD40_WDR5_VDV_2,1429-1434,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199614124,CHD7,missense,LIG_WD40_WDR5_VDV_2,2118-2122,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs199583200,CEP290,missense,LIG_WD40_WDR5_VDV_2,769-776,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200937785,FGA,missense,LIG_WD40_WDR5_VDV_2,851-858,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200937785,FGA,missense,LIG_WD40_WDR5_VDV_2,852-858,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs568033755,FGA,missense,LIG_WD40_WDR5_VDV_2,631-635,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs564329348,UNC13D,missense,LIG_WD40_WDR5_VDV_2,1082-1088,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544044508,PCDH15,missense,LIG_WD40_WDR5_VDV_2,1113-1119,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544044508,PCDH15,missense,LIG_WD40_WDR5_VDV_2,1118-1121,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs538978071,POLG,missense,LIG_WD40_WDR5_VDV_2,672-675,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs529029254,COL17A1,missense,LIG_WD40_WDR5_VDV_2,530-535,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs182072601,DFNB31,missense,LIG_WD40_WDR5_VDV_2,560-566,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs3802707,CDH23,missense,LIG_WD40_WDR5_VDV_2,556-561,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544861971,LRP5,missense,LIG_WD40_WDR5_VDV_2,63-68,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs544861971,LRP5,missense,LIG_WD40_WDR5_VDV_2,64-68,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61734502,LAMB3,missense,LIG_WD40_WDR5_VDV_2,230-237,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201753022,MYO7A,missense,LIG_WD40_WDR5_VDV_2,226-232,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs531205284,LRP5,missense,LIG_WD40_WDR5_VDV_2,1345-1351,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs374263890,DSP,missense,LIG_WD40_WDR5_VDV_2,1040-1047,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs35602796,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1863-1870,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs138929605,POLG,missense,LIG_WD40_WDR5_VDV_2,272-278,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs138929605,POLG,missense,LIG_WD40_WDR5_VDV_2,274-278,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540903138,KCNA5,missense,LIG_WD40_WDR5_VDV_2,527-534,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540903138,KCNA5,missense,LIG_WD40_WDR5_VDV_2,528-534,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540903138,KCNA5,missense,LIG_WD40_WDR5_VDV_2,530-534,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs540903138,KCNA5,missense,LIG_WD40_WDR5_VDV_2,531-534,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs537110423,BBS9,missense,LIG_WD40_WDR5_VDV_2,581-588,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567776263,LAMB3,missense,LIG_WD40_WDR5_VDV_2,944-947,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs556899786,BBS2,missense,LIG_WD40_WDR5_VDV_2,542-548,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567756521,CHD7,missense,LIG_WD40_WDR5_VDV_2,2179-2185,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs144860227,MFN2,missense,LIG_WD40_WDR5_VDV_2,716-723,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs570902880,SGCB,missense,LIG_WD40_WDR5_VDV_2,244-251,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34684955,NOD2,missense,LIG_WD40_WDR5_VDV_2,136-141,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs34731820,OCA2,missense,LIG_WD40_WDR5_VDV_2,370-376,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61734546,MKKS,missense,LIG_WD40_WDR5_VDV_2,488-493,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs55831733,PINK1,missense,LIG_WD40_WDR5_VDV_2,333-340,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs55831733,PINK1,missense,LIG_WD40_WDR5_VDV_2,335-340,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs61752783,POLG,missense,LIG_WD40_WDR5_VDV_2,511-517,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs149865858,WNT10A,missense,LIG_WD40_WDR5_VDV_2,42-49,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs567241943,RET,missense,LIG_WD40_WDR5_VDV_2,675-682,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs191121575,COL17A1,missense,LIG_WD40_WDR5_VDV_2,942-949,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs191121575,COL17A1,missense,LIG_WD40_WDR5_VDV_2,943-949,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs191121575,COL17A1,missense,LIG_WD40_WDR5_VDV_2,944-949,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571795495,BBS9,missense,LIG_WD40_WDR5_VDV_2,769-776,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571795495,BBS9,missense,LIG_WD40_WDR5_VDV_2,770-776,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571795495,BBS9,missense,LIG_WD40_WDR5_VDV_2,771-776,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs571795495,BBS9,missense,LIG_WD40_WDR5_VDV_2,773-776,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs140184929,UNC13D,missense,LIG_WD40_WDR5_VDV_2,863-868,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs147311278,PROKR2,missense,LIG_WD40_WDR5_VDV_2,379-385,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs6026,F5,missense,LIG_WD40_WDR5_VDV_2,1813-1820,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs6026,F5,missense,LIG_WD40_WDR5_VDV_2,1814-1820,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs541423556,IL17RD,missense,LIG_WD40_WDR5_VDV_2,76-83,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs532132864,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,105-111,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs568238049,BAAT,missense,LIG_WD40_WDR5_VDV_2,53-60,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs368070640,IL17RD,missense,LIG_WD40_WDR5_VDV_2,298-305,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs77704609,CHD7,missense,LIG_WD40_WDR5_VDV_2,2325-2330,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139827903,MFN2,missense,LIG_WD40_WDR5_VDV_2,73-80,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139827903,MFN2,missense,LIG_WD40_WDR5_VDV_2,77-80,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs561912072,SCN1A,missense,LIG_WD40_WDR5_VDV_2,846-852,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs561912072,SCN1A,missense,LIG_WD40_WDR5_VDV_2,851-857,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528685215,BBS2,missense,LIG_WD40_WDR5_VDV_2,286-292,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs528685215,BBS2,missense,LIG_WD40_WDR5_VDV_2,287-292,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs555662201,LAMB3,missense,LIG_WD40_WDR5_VDV_2,324-331,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs555662201,LAMB3,missense,LIG_WD40_WDR5_VDV_2,328-331,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs530481219,DSP,missense,LIG_WD40_WDR5_VDV_2,1367-1370,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201931861,SLC26A4,missense,LIG_WD40_WDR5_VDV_2,150-155,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs573131117,GNRHR,missense,LIG_WD40_WDR5_VDV_2,290-296,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs573131117,GNRHR,missense,LIG_WD40_WDR5_VDV_2,293-296,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs533137024,DFNB31,missense,LIG_WD40_WDR5_VDV_2,160-166,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs533137024,DFNB31,missense,LIG_WD40_WDR5_VDV_2,161-166,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs533137024,DFNB31,missense,LIG_WD40_WDR5_VDV_2,165-170,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs150282756,COL17A1,missense,LIG_WD40_WDR5_VDV_2,1320-1323,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs551619917,CHD7,missense,LIG_WD40_WDR5_VDV_2,2141-2148,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs551619917,CHD7,missense,LIG_WD40_WDR5_VDV_2,2142-2148,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs532463534,RBM20,missense,LIG_WD40_WDR5_VDV_2,206-212,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs144722609,UNC13D,missense,LIG_WD40_WDR5_VDV_2,199-204,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs542274936,BBS7,missense,LIG_WD40_WDR5_VDV_2,2-5,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs542735186,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1234-1240,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs542735186,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1236-1240,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs542735186,MYH7B,missense,LIG_WD40_WDR5_VDV_2,1237-1240,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201806207,NOD2,missense,LIG_WD40_WDR5_VDV_2,872-878,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs545693937,KCNJ10,missense,LIG_WD40_WDR5_VDV_2,189-196,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372337584,LRP5,missense,LIG_WD40_WDR5_VDV_2,363-369,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs372337584,LRP5,missense,LIG_WD40_WDR5_VDV_2,364-369,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs139014427,LRRK2,missense,LIG_WD40_WDR5_VDV_2,1710-1715,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs113917021,FZD4,missense,LIG_WD40_WDR5_VDV_2,16-21,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs574477065,MYO7A,missense,LIG_WD40_WDR5_VDV_2,503-509,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs201835496,PROKR2,missense,LIG_WD40_WDR5_VDV_2,178-182,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs200164044,COL17A1,missense,LIG_WD40_WDR5_VDV_2,530-535,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs11170164,KRT5,missense,LIG_WD40_WDR5_VDV_2,138-145,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs547514436,OCA2,missense,LIG_WD40_WDR5_VDV_2,458-462,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs536997345,LAMA1,missense,LIG_WD40_WDR5_VDV_2,1721-1728,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs104895452,NOD2,missense,LIG_WD40_WDR5_VDV_2,918-922,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs568593066,LRRK2,missense,LIG_WD40_WDR5_VDV_2,442-448,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs538167589,SCN2A,missense,LIG_WD40_WDR5_VDV_2,1464-1471,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs543360418,CPOX,missense,LIG_WD40_WDR5_VDV_2,21-26,,ELME000365,"WDR5 WD40 repeat (blade 5,6)-binding ligand","Fungi-specific variant of the WDR5-binding motif that binds to a cleft between blades 5 and 6 of the WD40 repeat domain of WDR5, opposite of the Win motif-binding site, to mediate assembly of histone modification complexes.","[EDSTY].{0,4}[VIPLA][TSDEKR][ILVA]",0.0467786304,2,0
rs6503640,KRT14,missense,LIG_14-3-3_CanoR_1,56-63,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs115215226,BAAT,missense,LIG_14-3-3_CanoR_1,117-122,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs201508063,CPT2,missense,LIG_14-3-3_CanoR_1,480-484,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs78219242,LRP5,missense,LIG_14-3-3_CanoR_1,88-92,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs541927296,KRT5,missense,LIG_14-3-3_CanoR_1,317-325,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs200847164,RNF216,missense,LIG_14-3-3_CanoR_1,895-899,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs35602796,LRRK2,missense,LIG_14-3-3_CanoR_1,1866-1871,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs200891884,UNC13D,missense,LIG_14-3-3_CanoR_1,97-101,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs151031345,KCNH2,missense,LIG_14-3-3_CanoR_1,1068-1074,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs55831733,PINK1,missense,LIG_14-3-3_CanoR_1,337-344,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs185337666,COL17A1,missense,LIG_14-3-3_CanoR_1,100-108,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs45475899,SCN5A,missense,LIG_14-3-3_CanoR_1,833-837,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs571092914,PARK2,missense,LIG_14-3-3_CanoR_1,396-403,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs568238049,BAAT,missense,LIG_14-3-3_CanoR_1,51-58,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs181366630,SLC26A4,missense,LIG_14-3-3_CanoR_1,640-648,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs187751757,CHD7,missense,LIG_14-3-3_CanoR_1,2914-2919,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs201806207,NOD2,missense,LIG_14-3-3_CanoR_1,870-874,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs530738094,SLC45A2,missense,LIG_14-3-3_CanoR_1,419-427,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs533409083,LRRK2,missense,LIG_14-3-3_CanoR_1,967-977,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs199887400,LRP5,missense,LIG_14-3-3_CanoR_1,1194-1201,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs550154172,DFNB31,missense,LIG_14-3-3_CanoR_1,157-166,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs41298759,MYO7A,missense,LIG_14-3-3_CanoR_1,2079-2085,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs545393299,LMNA,missense,LIG_14-3-3_CanoR_1,503-509,,ELME000417,14-3-3 binding phosphopeptide motif,Canonical Arg-containing phospho-motif mediating a strong interaction with 14-3-3 proteins.  ,"R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)|([^PRIKGN]P)|([^PRIKGN].{2,4}[VILMFWYP]))",0.0044766733,62,16
rs375140289,KRT5,missense,MOD_GlcNHglycan,520-523,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs572075052,CEP290,missense,MOD_GlcNHglycan,1169-1172,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200552541,LRP5,missense,MOD_GlcNHglycan,1400-1403,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200108255,MITF,missense,MOD_GlcNHglycan,206-209,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs554745483,PDZD7,missense,MOD_GlcNHglycan,357-360,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs146022149,KRT5,missense,MOD_GlcNHglycan,107-110,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs201264698,KRT5,missense,MOD_GlcNHglycan,41-44,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs530174336,OTUD4,missense,MOD_GlcNHglycan,246-249,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs534432274,BBS10,missense,MOD_GlcNHglycan,232-235,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs150401784,IL10RA,missense,MOD_GlcNHglycan,135-138,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs138457939,POLG,missense,MOD_GlcNHglycan,735-738,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs368543262,KRT5,missense,MOD_GlcNHglycan,117-120,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs190548814,CHD7,missense,MOD_GlcNHglycan,1232-1235,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs550851372,ROM1,missense,MOD_GlcNHglycan,31-34,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs545820701,OCA2,missense,MOD_GlcNHglycan,42-45,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs554913906,NPHS1,missense,MOD_GlcNHglycan,896-899,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs150282756,COL17A1,missense,MOD_GlcNHglycan,1321-1324,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs200051606,ABCC6,missense,MOD_GlcNHglycan,275-278,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs61735304,FZD4,missense,MOD_GlcNHglycan,32-35,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs192482410,FGG,missense,MOD_GlcNHglycan,376-379,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs532010385,BAAT,missense,MOD_GlcNHglycan,357-360,,ELME000085,Glycosaminoglycan attachment site,Glycosaminoglycan attachment site,"[ED]{0,3}.(S)[GA].",0.017919063,6,0
rs541292469,CHD7,missense,DOC_WW_Pin1_4,411-416,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs370265822,FGA,missense,DOC_WW_Pin1_4,251-256,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs568301918,MYO7A,missense,DOC_WW_Pin1_4,1200-1205,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs572501099,TYR,missense,DOC_WW_Pin1_4,413-418,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs557819500,KISS1R,missense,DOC_WW_Pin1_4,393-398,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs201587477,TACR3,missense,DOC_WW_Pin1_4,224-229,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs571899254,KCNQ1,missense,DOC_WW_Pin1_4,396-401,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs149298173,LAMA1,missense,DOC_WW_Pin1_4,1374-1379,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs144788254,LAMB3,missense,DOC_WW_Pin1_4,284-289,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs542522349,SGCB,missense,DOC_WW_Pin1_4,309-314,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs143604755,LAMA1,missense,DOC_WW_Pin1_4,1271-1276,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs138301552,NEUROD1,missense,DOC_WW_Pin1_4,188-193,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs61730754,PCDH15,missense,DOC_WW_Pin1_4,565-570,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs539433580,BAAT,missense,DOC_WW_Pin1_4,263-268,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs139277728,COL17A1,missense,DOC_WW_Pin1_4,449-454,,ELME000136,WW domain ligands,The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.,...([ST])P.,0.0154332128,96,1
rs541292469,CHD7,missense,MOD_CK1_1,414-420,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs562875924,KCNH2,missense,MOD_CK1_1,484-490,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs563411472,RBM20,missense,MOD_CK1_1,390-396,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs200592320,SLC3A1,missense,MOD_CK1_1,609-615,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs200806163,DSP,missense,MOD_CK1_1,220-226,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs571899254,KCNQ1,missense,MOD_CK1_1,399-405,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201319489,CHD7,missense,MOD_CK1_1,2683-2689,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs202230432,BBS2,missense,MOD_CK1_1,611-617,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs190548814,CHD7,missense,MOD_CK1_1,1230-1236,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs149865858,WNT10A,missense,MOD_CK1_1,39-45,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs552302426,MYH7,missense,MOD_CK1_1,158-164,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs138301552,NEUROD1,missense,MOD_CK1_1,191-197,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs374288473,BBS7,missense,MOD_CK1_1,378-384,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs113994098,POLG,missense,MOD_CK1_1,848-854,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs201835496,PROKR2,missense,MOD_CK1_1,178-184,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs144658100,CPT2,missense,MOD_CK1_1,339-345,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs41298759,MYO7A,missense,MOD_CK1_1,2080-2086,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs28936686,CAV3,missense,MOD_CK1_1,93-99,,ELME000063,CK1 Phosphorylation site,CK1 phosphorylation site,S..([ST])...,0.0170407403,2,0
rs541292469,CHD7,missense,MOD_ProDKin_1,411-417,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs370265822,FGA,missense,MOD_ProDKin_1,251-257,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs568301918,MYO7A,missense,MOD_ProDKin_1,1200-1206,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs572501099,TYR,missense,MOD_ProDKin_1,413-419,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs201587477,TACR3,missense,MOD_ProDKin_1,224-230,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs571899254,KCNQ1,missense,MOD_ProDKin_1,396-402,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs149298173,LAMA1,missense,MOD_ProDKin_1,1374-1380,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs144788254,LAMB3,missense,MOD_ProDKin_1,284-290,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs542522349,SGCB,missense,MOD_ProDKin_1,309-315,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs143604755,LAMA1,missense,MOD_ProDKin_1,1271-1277,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs138301552,NEUROD1,missense,MOD_ProDKin_1,188-194,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs61730754,PCDH15,missense,MOD_ProDKin_1,565-571,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs539433580,BAAT,missense,MOD_ProDKin_1,263-269,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs139277728,COL17A1,missense,MOD_ProDKin_1,449-455,,ELME000159,MAPK Phosphorylation Site,Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.,...([ST])P..,0.0154332128,36,0
rs375200447,RBM20,missense,MOD_GSK3_1,141-148,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs573017591,DSP,missense,MOD_GSK3_1,729-736,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs536616689,SCN1A,missense,MOD_GSK3_1,1931-1938,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs549381482,PROK2,missense,MOD_GSK3_1,42-49,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs533081002,GDAP1,missense,MOD_GSK3_1,238-245,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs188378450,IL10RA,missense,MOD_GSK3_1,102-109,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs151272575,ABCC6,missense,MOD_GSK3_1,685-692,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs147874812,NOD2,missense,MOD_GSK3_1,1029-1036,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199583200,CEP290,missense,MOD_GSK3_1,766-773,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201264698,KRT5,missense,MOD_GSK3_1,35-42,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs570511925,CD2AP,missense,MOD_GSK3_1,144-151,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs104895467,NOD2,missense,MOD_GSK3_1,849-856,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs543428644,KCNQ1,missense,MOD_GSK3_1,326-333,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200806163,DSP,missense,MOD_GSK3_1,220-227,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs201587477,TACR3,missense,MOD_GSK3_1,224-231,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs543964467,SLC45A2,missense,MOD_GSK3_1,416-423,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs571102620,NOD2,missense,MOD_GSK3_1,107-114,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs199472918,KCNH2,missense,MOD_GSK3_1,549-556,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs377604843,TMPRSS3,missense,MOD_GSK3_1,343-350,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs377604843,TMPRSS3,missense,MOD_GSK3_1,347-354,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs202230432,BBS2,missense,MOD_GSK3_1,611-618,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs34684955,NOD2,missense,MOD_GSK3_1,133-140,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs61734546,MKKS,missense,MOD_GSK3_1,481-488,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs55831733,PINK1,missense,MOD_GSK3_1,332-339,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs571795495,BBS9,missense,MOD_GSK3_1,768-775,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs143710836,LRRK2,missense,MOD_GSK3_1,1212-1219,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs121912691,SLC3A1,missense,MOD_GSK3_1,464-471,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs554913906,NPHS1,missense,MOD_GSK3_1,890-897,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs554913906,NPHS1,missense,MOD_GSK3_1,894-901,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs552087428,KCNQ1,missense,MOD_GSK3_1,654-661,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs74315448,KCNE2,missense,MOD_GSK3_1,54-61,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs528685215,BBS2,missense,MOD_GSK3_1,284-291,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs76838169,GJB2,missense,MOD_GSK3_1,196-203,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs368178632,CEP41,missense,MOD_GSK3_1,29-36,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs368178632,CEP41,missense,MOD_GSK3_1,33-40,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs117966637,MYO7A,missense,MOD_GSK3_1,1198-1205,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs533137024,DFNB31,missense,MOD_GSK3_1,162-169,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs568563702,TTC8,missense,MOD_GSK3_1,327-334,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs555356900,FOXC1,missense,MOD_GSK3_1,389-396,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs559446180,MYO7A,missense,MOD_GSK3_1,933-940,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs139014427,LRRK2,missense,MOD_GSK3_1,1703-1710,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs192482410,FGG,missense,MOD_GSK3_1,374-381,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs200963286,BAAT,missense,MOD_GSK3_1,330-337,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs536348228,PDZD7,missense,MOD_GSK3_1,355-362,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs573318480,TMPRSS3,missense,MOD_GSK3_1,338-345,,ELME000053,GSK3 phosphorylation site,GSK3 phosphorylation recognition site,...([ST])...[ST],0.0267865596,22,0
rs549579496,LRP5,missense,DOC_MAPK_gen_1,186-194,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs143318542,RNF216,missense,DOC_MAPK_gen_1,20-27,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs560377198,PINK1,missense,DOC_MAPK_gen_1,496-504,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs114718913,BBS7,missense,DOC_MAPK_gen_1,502-511,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs144937515,F5,missense,DOC_MAPK_gen_1,209-215,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs199876576,MYH7B,missense,DOC_MAPK_gen_1,864-872,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs545693937,KCNJ10,missense,DOC_MAPK_gen_1,193-200,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs550154172,DFNB31,missense,DOC_MAPK_gen_1,157-166,,ELME000233,MAPK docking motifs,"MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.","[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]",0.0043238,15,0
rs549579496,LRP5,missense,LIG_SUMO_SIM_par_1,188-193,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs563411472,RBM20,missense,LIG_SUMO_SIM_par_1,387-393,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs75876132,LAMB3,missense,LIG_SUMO_SIM_par_1,192-198,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs530174336,OTUD4,missense,LIG_SUMO_SIM_par_1,245-254,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs530174336,OTUD4,missense,LIG_SUMO_SIM_par_1,246-254,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs530174336,OTUD4,missense,LIG_SUMO_SIM_par_1,247-254,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs550851372,ROM1,missense,LIG_SUMO_SIM_par_1,25-32,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs550851372,ROM1,missense,LIG_SUMO_SIM_par_1,26-32,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs550851372,ROM1,missense,LIG_SUMO_SIM_par_1,32-39,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs61730754,PCDH15,missense,LIG_SUMO_SIM_par_1,561-568,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs61730754,PCDH15,missense,LIG_SUMO_SIM_par_1,562-568,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs61730754,PCDH15,missense,LIG_SUMO_SIM_par_1,563-568,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs61745150,OCA2,missense,LIG_SUMO_SIM_par_1,366-372,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs139014427,LRRK2,missense,LIG_SUMO_SIM_par_1,1710-1716,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs201835496,PROKR2,missense,LIG_SUMO_SIM_par_1,171-178,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs201835496,PROKR2,missense,LIG_SUMO_SIM_par_1,172-178,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs61735304,FZD4,missense,LIG_SUMO_SIM_par_1,27-33,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs547514436,OCA2,missense,LIG_SUMO_SIM_par_1,458-463,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs200399546,POLG,missense,LIG_SUMO_SIM_par_1,420-425,,ELME000333,SUMO interaction site,Motif for the parallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{0,5}.[VILPTM][VIL][DESTVILMA][VIL].{0,1}[DEST]{1,10}",0.004545201,33,4
rs572556762,NOD2,missense,CLV_PCSK_SKI1_1,132-136,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs542745694,JUP,missense,CLV_PCSK_SKI1_1,86-90,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs202117626,PCDH15,missense,CLV_PCSK_SKI1_1,1324-1328,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs199597323,UROD,missense,CLV_PCSK_SKI1_1,53-57,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs576165678,KISS1R,missense,CLV_PCSK_SKI1_1,233-237,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs145938787,FGG,missense,CLV_PCSK_SKI1_1,429-433,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs543428644,KCNQ1,missense,CLV_PCSK_SKI1_1,326-330,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs202096620,LAMB3,missense,CLV_PCSK_SKI1_1,440-444,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs35602796,LRRK2,missense,CLV_PCSK_SKI1_1,1866-1870,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs148897041,MTR,missense,CLV_PCSK_SKI1_1,658-662,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs536457955,PCDH15,missense,CLV_PCSK_SKI1_1,658-662,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs74315416,PROKR2,missense,CLV_PCSK_SKI1_1,173-177,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs199961311,NPHS1,missense,CLV_PCSK_SKI1_1,1237-1241,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs79887053,IL10RA,missense,CLV_PCSK_SKI1_1,451-455,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs144937515,F5,missense,CLV_PCSK_SKI1_1,210-214,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs187751757,CHD7,missense,CLV_PCSK_SKI1_1,2914-2918,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs144883021,LRRK2,missense,CLV_PCSK_SKI1_1,116-120,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs148714379,WNT10A,missense,CLV_PCSK_SKI1_1,167-171,,ELME000146,PCSK cleavage site,Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X).,[RK].[AILMFV][LTKF].,0.0068205274,2,0
rs572556762,NOD2,missense,MOD_SUMO_rev_2,127-136,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs567111510,NEK1,missense,MOD_SUMO_rev_2,320-329,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs541570788,CHD7,missense,MOD_SUMO_rev_2,2787-2792,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs570902880,SGCB,missense,MOD_SUMO_rev_2,244-251,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs566329616,LAMA1,missense,MOD_SUMO_rev_2,416-424,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs566329616,LAMA1,missense,MOD_SUMO_rev_2,417-424,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs143607861,BBS4,missense,MOD_SUMO_rev_2,386-391,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs528041468,DSP,missense,MOD_SUMO_rev_2,1778-1787,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs554813467,CPT2,missense,MOD_SUMO_rev_2,136-143,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs139827903,MFN2,missense,MOD_SUMO_rev_2,72-80,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs139827903,MFN2,missense,MOD_SUMO_rev_2,73-80,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs547319928,NEXN,missense,MOD_SUMO_rev_2,76-86,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs547319928,NEXN,missense,MOD_SUMO_rev_2,80-86,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs547319928,NEXN,missense,MOD_SUMO_rev_2,81-86,,ELME000393,Sumoylation site,Inverted version of SUMOylation motif recognized for modification by SUMO-1,"[SDE].{0,5}[DE].(K).{0,1}[AIFLMPSTV]",0.0128026465,20,0
rs562015789,DSP,missense,LIG_PTB_Apo_2,1859-1866,,ELME000122,PTB ligand,"These phosphorylation-independent motifs bind to Dab-like PTB domains. Binding is not driven by contacts at the 0 or FY position, but instead is dependent upon the large number of hydrophobic and hydrogen bond contacts between motif and domain.",(.[^P].NP.[FY].)|(.[ILVMFY].N..[FY].),0.0003108208,19,7
rs562015789,DSP,missense,LIG_PTB_Phospho_1,1859-1865,,ELME000095,PTB ligand,This phosphorylation-dependent motif binds to Shc-like and IRS-like PTB domains. The pTyr is positioned within a highly basic-charged anchoring pocket. A hydrophobic residue -5 (compared to pY) increases the affinity of the interaction.,(.[^P].NP.(Y))|(.[ILVMFY].N..(Y)),0.0001352405,17,6
rs571363075,JUP,missense,LIG_UBA3_1,304-309,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs186535471,LRP5,missense,LIG_UBA3_1,1176-1182,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs570326929,SCN1A,missense,LIG_UBA3_1,668-675,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs144586070,STXBP2,missense,LIG_UBA3_1,205-213,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs121909281,CAV3,missense,LIG_UBA3_1,13-20,,ELME000395,Binding motif for UBA3 adenylation domain,UBA3 adenylation domain binding motif variant based on the UBE2M and UBE2F interactions.,"[ILM][ILMF].{1,2}[ILM].{0,4}K",0.0011961589,2,0
rs76753586,PINK1,missense,LIG_FHA_2,357-363,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs573855825,UNC13D,missense,LIG_FHA_2,1006-1012,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs200241993,MYO7A,missense,LIG_FHA_2,203-209,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs45598239,TMPRSS3,missense,LIG_FHA_2,88-94,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs182072601,DFNB31,missense,LIG_FHA_2,558-564,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs202216621,MYO6,missense,LIG_FHA_2,768-774,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs571102620,NOD2,missense,LIG_FHA_2,108-114,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs148897041,MTR,missense,LIG_FHA_2,659-665,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs141851670,LAMA1,missense,LIG_FHA_2,962-968,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs146071220,MTR,missense,LIG_FHA_2,1111-1117,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs573318480,TMPRSS3,missense,LIG_FHA_2,343-349,,ELME000220,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.,..(T)..[DE].,0.0082864414,6,2
rs544017143,DSP,missense,DEG_COP1_1,501-508,,ELME000426,COP1 E3 ligase binding degron motif,A destruction motif interacts with the COP1 WD 40 domain for target ubiquitination and degradation.,"[STDE]{1,3}.{0,2}[TSDE].{2,3}VP[STDE]G{0,1}[FLIMVYPA]",0.0003906315,12,1
rs140264038,RNF216,missense,LIG_MYND_1,275-279,,ELME000145,MYND domain binding motif.,PxLxP motif is recognized by a subset of MYND domain containing proteins.,P.L.P,0.0006499374,6,0
rs201773048,LMBRD1,missense,LIG_LIR_Nem_3,14-18,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs567111510,NEK1,missense,LIG_LIR_Nem_3,320-324,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs137853058,PARK2,missense,LIG_LIR_Nem_3,207-212,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs575493480,CEP290,missense,LIG_LIR_Nem_3,277-283,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs575493480,CEP290,missense,LIG_LIR_Nem_3,279-283,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs543428644,KCNQ1,missense,LIG_LIR_Nem_3,329-335,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs200847164,RNF216,missense,LIG_LIR_Nem_3,897-903,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs538788331,SLC45A2,missense,LIG_LIR_Nem_3,368-374,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs200971340,MYOC,missense,LIG_LIR_Nem_3,127-131,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs201319489,CHD7,missense,LIG_LIR_Nem_3,2683-2688,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs543964467,SLC45A2,missense,LIG_LIR_Nem_3,419-425,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs138457939,POLG,missense,LIG_LIR_Nem_3,736-742,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs150947482,FZD4,missense,LIG_LIR_Nem_3,503-507,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143073792,TACR3,missense,LIG_LIR_Nem_3,410-416,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs61734546,MKKS,missense,LIG_LIR_Nem_3,488-493,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs528833454,MKKS,missense,LIG_LIR_Nem_3,49-53,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs59780231,KRT14,missense,LIG_LIR_Nem_3,413-418,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs143710836,LRRK2,missense,LIG_LIR_Nem_3,1215-1220,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs559464457,NEXN,missense,LIG_LIR_Nem_3,313-317,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs146148365,LAMA1,missense,LIG_LIR_Nem_3,2282-2288,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs541386535,IL10RA,missense,LIG_LIR_Nem_3,239-245,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs568238049,BAAT,missense,LIG_LIR_Nem_3,53-58,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs74315448,KCNE2,missense,LIG_LIR_Nem_3,57-63,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs119103267,MFN2,missense,LIG_LIR_Nem_3,704-710,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs119103267,MFN2,missense,LIG_LIR_Nem_3,706-710,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs544316711,SCN1A,missense,LIG_LIR_Nem_3,1866-1871,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs202053997,RET,missense,LIG_LIR_Nem_3,428-433,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs556996220,PRF1,missense,LIG_LIR_Nem_3,344-350,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs533137024,DFNB31,missense,LIG_LIR_Nem_3,165-170,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs201806207,NOD2,missense,LIG_LIR_Nem_3,872-876,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs550530605,IL10RA,missense,LIG_LIR_Nem_3,538-544,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs550530605,IL10RA,missense,LIG_LIR_Nem_3,540-544,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs147407423,POLG,missense,LIG_LIR_Nem_3,608-613,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs190174945,BAAT,missense,LIG_LIR_Nem_3,76-82,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs149760791,BBS10,missense,LIG_LIR_Nem_3,246-251,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs115489112,NPHS1,missense,LIG_LIR_Nem_3,1168-1174,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs140681784,LAMA1,missense,LIG_LIR_Nem_3,1052-1058,,ELME000370,Atg8 protein family ligands,Nematode-specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..[ILVFY]",0.0063621022,1,0
rs200552541,LRP5,missense,MOD_NEK2_1,1398-1403,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs573017591,DSP,missense,MOD_NEK2_1,729-734,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs201496378,BBS4,missense,MOD_NEK2_1,213-218,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs146022149,KRT5,missense,MOD_NEK2_1,105-110,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs548952092,IL17RD,missense,MOD_NEK2_1,480-485,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs200113018,OTUD4,missense,MOD_NEK2_1,723-728,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs150088620,LRP5,missense,MOD_NEK2_1,1342-1347,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs186535471,LRP5,missense,MOD_NEK2_1,1180-1185,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs368543262,KRT5,missense,MOD_NEK2_1,115-120,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs140352947,KRT5,missense,MOD_NEK2_1,516-521,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs190631149,LRRK2,missense,MOD_NEK2_1,679-684,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs532132864,SLC26A4,missense,MOD_NEK2_1,107-112,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs74315448,KCNE2,missense,MOD_NEK2_1,54-59,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs573922051,SLC45A2,missense,MOD_NEK2_1,94-99,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs558673680,MYH7,missense,MOD_NEK2_1,863-868,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs568496266,PYGM,missense,MOD_NEK2_1,447-452,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs187841130,FGG,missense,MOD_NEK2_1,428-433,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs115353346,UNC13D,missense,MOD_NEK2_1,710-715,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs148871409,PINK1,missense,MOD_NEK2_1,115-120,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs542274936,BBS7,missense,MOD_NEK2_1,1-6,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs549128015,F5,missense,MOD_NEK2_1,1572-1577,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs565726855,PDX1,missense,MOD_NEK2_1,151-156,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs61735304,FZD4,missense,MOD_NEK2_1,30-35,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs532010385,BAAT,missense,MOD_NEK2_1,355-360,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs200934424,MYO7A,missense,MOD_NEK2_1,1434-1439,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs142137272,KRT14,missense,MOD_NEK2_1,65-70,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs533478642,OCA2,missense,MOD_NEK2_1,350-355,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs28936686,CAV3,missense,MOD_NEK2_1,90-95,,ELME000336,NEK2 phosphorylation site,"NEK2 phosphorylation motif with preferred Phe, Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.",[FLM][^P][^P]([ST])[^DEP][^DE],0.0097982858,3,0
rs561266462,ABCC6,missense,LIG_SH3_3,184-190,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs143725782,LAMB3,missense,LIG_SH3_3,228-234,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs552811471,F5,missense,LIG_SH3_3,138-144,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs376934539,CHD7,missense,LIG_SH3_3,2786-2792,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs567017513,RBM20,missense,LIG_SH3_3,712-718,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs367836027,NEK1,missense,LIG_SH3_3,1039-1045,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs199951066,ABCC6,missense,LIG_SH3_3,691-697,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs550530605,IL10RA,missense,LIG_SH3_3,541-547,,ELME000155,SH3 ligand,This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity,...[PV]..P,0.0131729137,16,1
rs141947938,CHD7,missense,MOD_PLK,741-747,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs566111152,MYO7A,missense,MOD_PLK,595-601,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs151272575,ABCC6,missense,MOD_PLK,689-695,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs199583200,CEP290,missense,MOD_PLK,766-772,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs538978071,POLG,missense,MOD_PLK,671-677,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs199728804,PYGM,missense,MOD_PLK,433-439,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs540903138,KCNA5,missense,MOD_PLK,530-536,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs148112458,GNRHR,missense,MOD_PLK,155-161,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs571795495,BBS9,missense,MOD_PLK,772-778,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs202136369,PCDH15,missense,MOD_PLK,792-798,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs119103267,MFN2,missense,MOD_PLK,703-709,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs555662201,LAMB3,missense,MOD_PLK,327-333,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs145532615,MYH7,missense,MOD_PLK,979-985,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs149067043,PYGM,missense,MOD_PLK,251-257,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs200431470,SLC26A4,missense,MOD_PLK,265-271,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs542274936,BBS7,missense,MOD_PLK,1-7,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs542735186,MYH7B,missense,MOD_PLK,1236-1242,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs115690781,PYGM,missense,MOD_PLK,256-262,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs34637584,LRRK2,missense,MOD_PLK,2016-2022,,ELME000147,Plk phosphorylation site,Site phosphorylated by the Polo-like kinase.,.[DE].([ST])[ILFWMVA]..,0.0060145592,2,0
rs200387103,WNT10A,missense,CLV_NRD_NRD_1,250-252,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs202117626,PCDH15,missense,CLV_NRD_NRD_1,1322-1324,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs137853579,IL10RA,missense,CLV_NRD_NRD_1,140-142,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs540286145,LAMB3,missense,CLV_NRD_NRD_1,568-570,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs576306073,SCN1A,missense,CLV_NRD_NRD_1,1019-1021,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs151031345,KCNH2,missense,CLV_NRD_NRD_1,1068-1070,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs148695069,PDZD7,missense,CLV_NRD_NRD_1,102-104,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs536457955,PCDH15,missense,CLV_NRD_NRD_1,658-660,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs199749712,USH1C,missense,CLV_NRD_NRD_1,54-56,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs142496524,ROM1,missense,CLV_NRD_NRD_1,170-172,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs140997623,BBS4,missense,CLV_NRD_NRD_1,516-518,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs543939499,PINK1,missense,CLV_NRD_NRD_1,193-195,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs143068960,SLC3A1,missense,CLV_NRD_NRD_1,376-378,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs200885801,OCA2,missense,CLV_NRD_NRD_1,52-54,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs551533386,CEP290,missense,CLV_NRD_NRD_1,434-436,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs551819918,RBM20,missense,CLV_NRD_NRD_1,715-717,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs201186588,IL10RA,missense,CLV_NRD_NRD_1,147-149,,ELME000102,NRD cleavage site,N-Arg dibasic convertase (NRD/Nardilysin) cleavage site (X-|-R-K or R-|-R-X).,(.RK)|(RR[^KR]),0.0074647325,2,0
rs200387103,WNT10A,missense,CLV_PCSK_FUR_1,248-252,,ELME000101,PCSK cleavage site,Furin (PACE) cleavage site (R-X-[RK]-R-|-X).,R.[RK]R.,0.0005087229,13,0
rs200387103,WNT10A,missense,CLV_PCSK_KEX2_1,250-252,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs540286145,LAMB3,missense,CLV_PCSK_KEX2_1,568-570,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs151031345,KCNH2,missense,CLV_PCSK_KEX2_1,1068-1070,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs148695069,PDZD7,missense,CLV_PCSK_KEX2_1,102-104,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs536457955,PCDH15,missense,CLV_PCSK_KEX2_1,658-660,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs190416018,RBM20,missense,CLV_PCSK_KEX2_1,725-727,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs199749712,USH1C,missense,CLV_PCSK_KEX2_1,54-56,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs142496524,ROM1,missense,CLV_PCSK_KEX2_1,170-172,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs543939499,PINK1,missense,CLV_PCSK_KEX2_1,193-195,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs41494349,LRP5,missense,CLV_PCSK_KEX2_1,88-90,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs143068960,SLC3A1,missense,CLV_PCSK_KEX2_1,376-378,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs200885801,OCA2,missense,CLV_PCSK_KEX2_1,52-54,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs201186588,IL10RA,missense,CLV_PCSK_KEX2_1,147-149,,ELME000108,PCSK cleavage site,Yeast kexin 2 cleavage site (K-R-|-X or R-R-|-X).,[KR]R.,0.0079734635,1,0
rs200387103,WNT10A,missense,TRG_ER_diArg_1,248-251,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs200387103,WNT10A,missense,TRG_ER_diArg_1,249-251,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs188810322,PCDH15,missense,TRG_ER_diArg_1,36-39,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs529676674,ABCC6,missense,TRG_ER_diArg_1,986-989,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs529676674,ABCC6,missense,TRG_ER_diArg_1,987-990,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs138929605,POLG,missense,TRG_ER_diArg_1,275-278,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs151031345,KCNH2,missense,TRG_ER_diArg_1,1067-1069,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs148695069,PDZD7,missense,TRG_ER_diArg_1,101-103,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs536457955,PCDH15,missense,TRG_ER_diArg_1,657-659,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs536457955,PCDH15,missense,TRG_ER_diArg_1,658-660,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs188909481,LRP5,missense,TRG_ER_diArg_1,1467-1470,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs199749712,USH1C,missense,TRG_ER_diArg_1,53-55,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs199749712,USH1C,missense,TRG_ER_diArg_1,54-56,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs543939499,PINK1,missense,TRG_ER_diArg_1,192-194,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201047984,RBM20,missense,TRG_ER_diArg_1,364-367,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201047984,RBM20,missense,TRG_ER_diArg_1,365-368,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs143068960,SLC3A1,missense,TRG_ER_diArg_1,375-377,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs143068960,SLC3A1,missense,TRG_ER_diArg_1,376-378,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs565726855,PDX1,missense,TRG_ER_diArg_1,148-151,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs550154172,DFNB31,missense,TRG_ER_diArg_1,156-159,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs201186588,IL10RA,missense,TRG_ER_diArg_1,146-148,,ELME000012,di Arginine retention/retrieving signal,The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.,"([LIVMFYWPR]R[^YFWDE]{0,1}R)|(R[^YFWDE]{0,1}R[LIVMFYWPR])",0.0053692734,27,0
rs200387103,WNT10A,missense,TRG_NLS_Bipartite_1,250-264,,ELME000276,NLS classical Nuclear Localization Signals,Bipartite variant of the classical basically charged NLS.,"[KR][KR].{7,15}[^DE]((K[RK])|(RK))(([^DE][KR])|([KR][^DE]))[^DE]",0.0002587966,9,4
rs201830202,LAMB3,missense,DOC_USP7_UBL2_3,64-68,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs202117626,PCDH15,missense,DOC_USP7_UBL2_3,1324-1328,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs2307450,POLG,missense,DOC_USP7_UBL2_3,658-662,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs200197882,LRRK2,missense,DOC_USP7_UBL2_3,1459-1463,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs28939695,NPHS1,missense,DOC_USP7_UBL2_3,443-447,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs530654635,F5,missense,DOC_USP7_UBL2_3,1758-1762,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs190618510,KAL1,missense,DOC_USP7_UBL2_3,404-408,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs187073962,MYH7,missense,DOC_USP7_UBL2_3,1898-1902,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs183412632,KCNE1,missense,DOC_USP7_UBL2_3,15-19,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs104895432,NOD2,missense,DOC_USP7_UBL2_3,441-445,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs200345240,NEXN,missense,DOC_USP7_UBL2_3,32-36,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs147188917,CD2AP,missense,DOC_USP7_UBL2_3,312-316,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs528041468,DSP,missense,DOC_USP7_UBL2_3,1785-1789,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs558673680,MYH7,missense,DOC_USP7_UBL2_3,867-871,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs202159966,CEP290,missense,DOC_USP7_UBL2_3,171-175,,ELME000394,USP7 binding motif,The USP7 CTD domain binding motif variant based on the ICP0 and DNMT1 interactions,K...K,0.0037417689,0,0
rs562014636,SLC7A9,missense,LIG_EH1_1,321-329,,ELME000148,eh1 motif,"The engrailed homology domain 1 motif is found in homeodomain containing active repressors and other transcription families, and allows for the recruitment of Groucho/TLE corepressors.",.[FYH].[IVM][^WFYP][^WFYP][ILM][ILMV].,7.85797550811e-05,11,1
rs542558237,NOD2,missense,MOD_CK2_1,930-936,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs199614124,CHD7,missense,MOD_CK2_1,2115-2121,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs568301918,MYO7A,missense,MOD_CK2_1,1200-1206,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs538978071,POLG,missense,MOD_CK2_1,671-677,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs148112458,GNRHR,missense,MOD_CK2_1,150-156,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs190631149,LRRK2,missense,MOD_CK2_1,679-685,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs140461312,LAMA1,missense,MOD_CK2_1,2283-2289,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs528685215,BBS2,missense,MOD_CK2_1,288-294,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs570691119,CHD7,missense,MOD_CK2_1,1813-1819,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs201777547,IL10RA,missense,MOD_CK2_1,292-298,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs552086854,RNF216,missense,MOD_CK2_1,2-8,,ELME000064,CK2 Phosphorylation site,CK2 phosphorylation site,...([ST])..E,0.0145680743,10,0
rs549381482,PROK2,missense,MOD_OFUCOSY,40-46,,ELME000162,O-Fucosylation site,Site for attachment of a fucose residue to a serine.,"C.{3,5}([ST])C",4.61694301554e-05,4,0
rs137852752,BMPR2,missense,DOC_USP7_MATH_1,899-903,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs188378450,IL10RA,missense,DOC_USP7_MATH_1,102-106,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs28763958,DSP,missense,DOC_USP7_MATH_1,112-116,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs556972226,SGCB,missense,DOC_USP7_MATH_1,313-317,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs201319489,CHD7,missense,DOC_USP7_MATH_1,2680-2684,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs202194206,DSP,missense,DOC_USP7_MATH_1,35-39,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs138806570,KRT5,missense,DOC_USP7_MATH_1,91-95,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs550851372,ROM1,missense,DOC_USP7_MATH_1,29-33,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs554813467,CPT2,missense,DOC_USP7_MATH_1,133-137,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs144703247,CPT2,missense,DOC_USP7_MATH_1,533-537,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs528685215,BBS2,missense,DOC_USP7_MATH_1,288-292,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs554967424,RAB27A,missense,DOC_USP7_MATH_1,198-202,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs574477065,MYO7A,missense,DOC_USP7_MATH_1,500-504,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs201835496,PROKR2,missense,DOC_USP7_MATH_1,175-179,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs201261098,KRT14,missense,DOC_USP7_MATH_1,259-263,,ELME000239,USP7 binding motif,The USP7 MATH domain binding motif variant based on the MDM2 and p53 interactions.,[PA][^P][^FYWIL]S[^P],0.0123884987,10,6
rs542745694,JUP,missense,MOD_PKB_1,84-92,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs559446180,MYO7A,missense,MOD_PKB_1,931-939,,ELME000061,PKB Phosphorylation site,PKB Phosphorylation site,R.R..([ST])[^P]..,0.0006034092,20,1
rs570914443,OCA2,missense,DOC_CYCLIN_1,352-355,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs202117626,PCDH15,missense,DOC_CYCLIN_1,1324-1327,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs34282765,STX11,missense,DOC_CYCLIN_1,276-280,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs190618510,KAL1,missense,DOC_CYCLIN_1,404-407,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs142689095,LAMB3,missense,DOC_CYCLIN_1,618-621,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs199961311,NPHS1,missense,DOC_CYCLIN_1,1237-1241,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs199749712,USH1C,missense,DOC_CYCLIN_1,54-58,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs543782711,OTUD4,missense,DOC_CYCLIN_1,234-237,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs187751757,CHD7,missense,DOC_CYCLIN_1,2914-2918,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs149953814,PARK2,missense,DOC_CYCLIN_1,435-439,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs142054672,PYGM,missense,DOC_CYCLIN_1,410-413,,ELME000106,Cyclin recognition site,Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.,"[RK].L.{0,1}[FYLIVMP]",0.0053239246,24,6
rs533081002,GDAP1,missense,LIG_BRCT_BRCA1_1,240-244,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs138806570,KRT5,missense,LIG_BRCT_BRCA1_1,93-97,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs150622626,PYGM,missense,LIG_BRCT_BRCA1_1,595-599,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs541386535,IL10RA,missense,LIG_BRCT_BRCA1_1,238-242,,ELME000197,BRCT phosphopeptide ligands,Phosphopeptide motif which directly interacts with the BRCT (carboxy-terminal) domain  of the Breast Cancer Gene BRCA1 with low affinity,.(S)..F,0.0019115207,5,3
rs55824996,LAMB3,missense,MOD_Cter_Amidation,110-113,,ELME000093,Peptide Amidation Site,Peptide C-terminal amidation,(.)G[RK][RK],0.0011550292,0,0
rs370265822,FGA,missense,MOD_CDK_SPxxK_3,251-258,,ELME000428,CDK Phosphorylation Site,Longer version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at position +4 after the phospho-Ser/Thr,...([ST])P..[RK],0.0019287195,25,0
rs568301918,MYO7A,missense,MOD_CDK_SPxxK_3,1200-1207,,ELME000428,CDK Phosphorylation Site,Longer version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at position +4 after the phospho-Ser/Thr,...([ST])P..[RK],0.0019287195,25,0
rs565524160,RBM20,missense,MOD_CDK_SPxxK_3,1084-1091,,ELME000428,CDK Phosphorylation Site,Longer version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at position +4 after the phospho-Ser/Thr,...([ST])P..[RK],0.0019287195,25,0
rs576165678,KISS1R,missense,LIG_Actin_WH2_2,224-239,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs137853579,IL10RA,missense,LIG_Actin_WH2_2,127-143,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs2307450,POLG,missense,LIG_Actin_WH2_2,648-664,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs56143179,IL10RA,missense,LIG_Actin_WH2_2,289-305,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs201777547,IL10RA,missense,LIG_Actin_WH2_2,289-305,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs570519739,LRRK2,missense,LIG_Actin_WH2_2,1748-1766,,ELME000313,Actin-binding motifs,The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.,"[^R]..((.[ILMVF])|([ILMVF].))[^P][^P][ILVM].{4,7}L(([KR].)|(NK))[VATIGS]",0.000660305,13,1
rs200197882,LRRK2,missense,DOC_MAPK_RevD_3,1446-1460,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs139827903,MFN2,missense,DOC_MAPK_RevD_3,80-95,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs55662069,MYO6,missense,DOC_MAPK_RevD_3,835-849,,ELME000411,MAPK docking motifs,Reverse (C to N direction) of the classical MAPK docking motif ELM:DOC_MAPK_gen_1 with an often extended linker region of the bipartite motif.,"[LIVMPFA].[LIV].{1,2}[LIVMP].{4,6}[LIV]..[RK][RK]",0.000180483,6,3
rs199725550,KAL1,missense,MOD_NEK2_2,147-152,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs545734771,NOD2,missense,MOD_NEK2_2,925-930,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs200885801,OCA2,missense,MOD_NEK2_2,47-52,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs535808030,STXBP2,missense,MOD_NEK2_2,95-100,,ELME000337,NEK2 phosphorylation site,NEK2 phosphorylation motif with specific set of residues in the +1 and +2 position to compensate for less favorable residues in the -3 position.,[WYPCAG][^P][^P]([ST])[IFCVML][KRHYF],0.0012950344,0,0
rs397516601,RBM20,missense,LIG_SH2_STAT5,737-740,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs201920649,TYR,missense,LIG_SH2_STAT5,251-254,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs34282765,STX11,missense,LIG_SH2_STAT5,280-283,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs537110423,BBS9,missense,LIG_SH2_STAT5,581-584,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs532733379,TTC8,missense,LIG_SH2_STAT5,241-244,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs114246406,ABCC6,missense,LIG_SH2_STAT5,790-793,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs542672517,CHD7,missense,LIG_SH2_STAT5,192-195,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs556996220,PRF1,missense,LIG_SH2_STAT5,347-350,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs151179820,GJB3,missense,LIG_SH2_STAT5,97-100,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs143517122,PDX1,missense,LIG_SH2_STAT5,139-142,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs115489112,NPHS1,missense,LIG_SH2_STAT5,1174-1177,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs568593066,LRRK2,missense,LIG_SH2_STAT5,442-445,,ELME000182,SH2 ligand,STAT5 Src Homology 2 (SH2) domain binding motif.,(Y)[VLTFIC]..,0.0032958712,19,0
rs575493480,CEP290,missense,TRG_ENDOCYTIC_2,280-283,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs538788331,SLC45A2,missense,TRG_ENDOCYTIC_2,371-374,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs534913364,KRT5,missense,TRG_ENDOCYTIC_2,95-98,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs556996220,PRF1,missense,TRG_ENDOCYTIC_2,347-350,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs36039758,SLC26A4,missense,TRG_ENDOCYTIC_2,324-327,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs149760791,BBS10,missense,TRG_ENDOCYTIC_2,248-251,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs568593066,LRRK2,missense,TRG_ENDOCYTIC_2,442-445,,ELME000120,Y-based sorting signal,Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex,Y..[LMVIF],0.0025874919,15,1
rs149229372,ABCC9,missense,LIG_FHA_1,604-610,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs74653330,OCA2,missense,LIG_FHA_1,479-485,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs372497706,LAMA1,missense,LIG_FHA_1,1476-1482,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs534094626,RET,missense,LIG_FHA_1,740-746,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs56143179,IL10RA,missense,LIG_FHA_1,290-296,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs139829784,LAMB3,missense,LIG_FHA_1,930-936,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs185337666,COL17A1,missense,LIG_FHA_1,103-109,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs368070640,IL17RD,missense,LIG_FHA_1,296-302,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs375609644,CEP290,missense,LIG_FHA_1,1258-1264,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs187841130,FGG,missense,LIG_FHA_1,429-435,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs145532615,MYH7,missense,LIG_FHA_1,980-986,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs61730754,PCDH15,missense,LIG_FHA_1,566-572,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs532463534,RBM20,missense,LIG_FHA_1,209-215,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs539433580,BAAT,missense,LIG_FHA_1,264-270,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs542735186,MYH7B,missense,LIG_FHA_1,1237-1243,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs144429522,GGCX,missense,LIG_FHA_1,450-456,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs78257946,FGG,missense,LIG_FHA_1,365-371,,ELME000052,FHA phosphopeptide ligands,Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.,..(T)..[ILV].,0.0086622425,5,3
rs200241993,MYO7A,missense,CLV_C14_Caspase3-7,205-209,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs111033363,PCDH15,missense,CLV_C14_Caspase3-7,1269-1273,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs571102620,NOD2,missense,CLV_C14_Caspase3-7,110-114,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs571212778,LRP5,missense,CLV_C14_Caspase3-7,1230-1234,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs536127246,CEP290,missense,CLV_C14_Caspase3-7,318-322,,ELME000321,Caspase cleavage motif,Caspase-3 and Caspase-7 cleavage site.,[DSTE][^P][^DEWHFYC]D[GSAN],0.0030937403,39,0
rs193098360,WNT10A,missense,LIG_Pex14_2,228-232,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs145254330,SLC26A4,missense,LIG_Pex14_2,117-121,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs56092260,PARK2,missense,LIG_Pex14_2,362-366,,ELME000328,Pex14 ligand motif,"Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member, Pex14",F...[WF],0.000462812,2,0
rs201508063,CPT2,missense,MOD_PKA_2,479-485,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs78219242,LRP5,missense,MOD_PKA_2,87-93,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs139773124,TTC8,missense,MOD_PKA_2,410-416,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs541927296,KRT5,missense,MOD_PKA_2,316-322,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs200847164,RNF216,missense,MOD_PKA_2,894-900,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs201753022,MYO7A,missense,MOD_PKA_2,223-229,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs200891884,UNC13D,missense,MOD_PKA_2,96-102,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs148695069,PDZD7,missense,MOD_PKA_2,102-108,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs34684955,NOD2,missense,MOD_PKA_2,137-143,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs55831733,PINK1,missense,MOD_PKA_2,336-342,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs184498773,RET,missense,MOD_PKA_2,677-683,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs45475899,SCN5A,missense,MOD_PKA_2,832-838,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs571092914,PARK2,missense,MOD_PKA_2,395-401,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs568238049,BAAT,missense,MOD_PKA_2,50-56,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs181366630,SLC26A4,missense,MOD_PKA_2,639-645,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs552077922,PARK2,missense,MOD_PKA_2,88-94,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs200051606,ABCC6,missense,MOD_PKA_2,273-279,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs201806207,NOD2,missense,MOD_PKA_2,869-875,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs143762350,TMPRSS3,missense,MOD_PKA_2,93-99,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs549128015,F5,missense,MOD_PKA_2,1572-1578,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs199887400,LRP5,missense,MOD_PKA_2,1193-1199,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs545393299,LMNA,missense,MOD_PKA_2,502-508,,ELME000062,PKA Phosphorylation site,Secondary preference for PKA-type AGC kinase phosphorylation.,.R.([ST])[^P]..,0.0094575274,28,0
rs534588814,PCDH15,missense,LIG_TRFH_1,1311-1315,,ELME000249,TRFH domain docking motifs,TRF1 and TRF2 both bind to another shelterin protein: TIN2. The TRF1-TIN2 interaction was mediated by a short motif in the N-Ter of TIN2. TIN2 connects TRF1 to TRF2; this link contributes to the stabilization of TRF2 on telomeres.,[FY].L.P,0.0002240046,3,2
rs183101063,OCA2,missense,LIG_TRFH_1,827-831,,ELME000249,TRFH domain docking motifs,TRF1 and TRF2 both bind to another shelterin protein: TIN2. The TRF1-TIN2 interaction was mediated by a short motif in the N-Ter of TIN2. TIN2 connects TRF1 to TRF2; this link contributes to the stabilization of TRF2 on telomeres.,[FY].L.P,0.0002240046,3,2
rs558440102,LRRK2,missense,TRG_LysEnd_APsAcLL_1,1822-1827,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs529676674,ABCC6,missense,TRG_LysEnd_APsAcLL_1,989-994,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs368115484,LAMB3,missense,TRG_LysEnd_APsAcLL_1,1059-1064,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs56143179,IL10RA,missense,TRG_LysEnd_APsAcLL_1,291-296,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs142689095,LAMB3,missense,TRG_LysEnd_APsAcLL_1,616-621,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs78652302,DSP,missense,TRG_LysEnd_APsAcLL_1,1828-1833,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs199961311,NPHS1,missense,TRG_LysEnd_APsAcLL_1,1235-1240,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs143494121,MYO7A,missense,TRG_LysEnd_APsAcLL_1,1035-1040,,ELME000149,Endosome-Lysosome-Basolateral sorting signals,Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes,[DERQ]...L[LVI],0.0027576716,16,1
rs190705310,MFN2,missense,LIG_TRAF2_1,536-539,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs565042936,MFN2,missense,LIG_TRAF2_1,382-385,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs202095584,LAMB3,missense,LIG_TRAF2_1,501-504,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs56175199,CYP1B1,missense,LIG_TRAF2_1,435-438,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs543448239,MYO7A,missense,LIG_TRAF2_1,932-935,,ELME000117,TRAF2 binding site,Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.,[PSAT].[QE]E,0.0042998127,14,6
rs372474695,CHD7,missense,DOC_PP1_RVXF_1,884-891,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs142286849,FGG,missense,DOC_PP1_RVXF_1,86-93,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs200728516,LRP5,missense,DOC_PP1_RVXF_1,173-179,,ELME000137,PP1-docking motif RVXF,"Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0,1}[VI][^P][FW].","..[RK].{0,1}[VIL][^P][FW].",0.0008301444,19,4
rs80358282,FZD4,missense,LIG_SH2_STAT3,69-72,,ELME000163,SH2 ligand,YXXQ motif found in the cytoplasmic region of cytokine receptors that bind STAT3 SH2 domain.,(Y)..Q,0.0007974958,9,0
rs201256460,FZD4,missense,MOD_SUMO_for_1,527-530,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs144278838,LAMA1,missense,MOD_SUMO_for_1,410-413,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs567756521,CHD7,missense,MOD_SUMO_for_1,2185-2188,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs535347450,CHD7,missense,MOD_SUMO_for_1,1929-1932,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs578119372,PDZD7,missense,MOD_SUMO_for_1,472-475,,ELME000002,Sumoylation site,Motif recognised for modification by SUMO-1,[VILMAFP](K).E,0.0019140007,45,1
rs61734502,LAMB3,missense,LIG_LIR_Apic_2,230-235,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs150622626,PYGM,missense,LIG_LIR_Apic_2,596-601,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs121912691,SLC3A1,missense,LIG_LIR_Apic_2,467-473,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs28369373,LAMA1,missense,LIG_LIR_Apic_2,775-780,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs529002760,MYO6,missense,LIG_LIR_Apic_2,530-536,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs529002760,MYO6,missense,LIG_LIR_Apic_2,531-536,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs529002760,MYO6,missense,LIG_LIR_Apic_2,532-536,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs139544114,KCNH2,missense,LIG_LIR_Apic_2,145-151,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs201004645,GJB2,missense,LIG_LIR_Apic_2,171-175,,ELME000369,Atg8 protein family ligands,Apicomplexa specific variant of the canonical LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}[WFY]..P",0.0033709643,1,1
rs201753022,MYO7A,missense,MOD_PKA_1,223-229,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs148695069,PDZD7,missense,MOD_PKA_1,102-108,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs148897041,MTR,missense,MOD_PKA_1,658-664,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs184498773,RET,missense,MOD_PKA_1,677-683,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs200051606,ABCC6,missense,MOD_PKA_1,273-279,,ELME000008,PKA Phosphorylation site,Main preference for PKA-type AGC kinase phosphorylation.,[RK][RK].([ST])[^P]..,0.0023150947,25,0
rs538788331,SLC45A2,missense,LIG_TYR_ITIM,369-374,,ELME000020,Immunoreceptor tyrosine-based motif,"ITIM (immunoreceptor tyrosine-based inhibitory motif). Phosphorylation of the ITIM motif, found in the cytoplasmic tail of some inhibitory receptors (KIRs) that bind MHC Class I, leads to the recruitment and activation of a protein tyrosine phosphatase.",[ILV].(Y)..[ILV],0.000299241,7,0
rs557819500,KISS1R,missense,LIG_PDZ_Class_1,393-398,,ELME000086,PDZ ligands,The C-terminal class 1 PDZ-binding motif is classically represented by a pattern like (ST)X(VIL)*,...[ST].[ACVILF]$,7.25453204794e-05,48,24
rs200243831,GNRHR,missense,LIG_PDZ_Class_1,324-329,,ELME000086,PDZ ligands,The C-terminal class 1 PDZ-binding motif is classically represented by a pattern like (ST)X(VIL)*,...[ST].[ACVILF]$,7.25453204794e-05,48,24
rs201587477,TACR3,missense,DEG_SCF_FBW7_1,226-231,,ELME000289,SCF ubiquitin ligase binding Phosphodegrons,The TPxxS phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..([ST])",0.0007138326,6,2
rs201587477,TACR3,missense,MOD_CDK_SPxK_1,224-230,,ELME000153,CDK Phosphorylation Site,Canonical version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at the [ST]+3 position.,...([ST])P.[KR],0.0019287195,24,1
rs200054554,COL17A1,missense,LIG_RGD,754-756,,ELME000094,Integrin binding sites,The RGD motif can be found in many proteins of the extracellular matrix and it is recognized by different members of the integrin family. The structure of the tenth type III module of fibronectin has  shown that the RGD motif lies on an exposed flexible lo,RGD,0.0002366175,21,1
rs149897775,DFNB31,missense,DOC_PP2A_B56_1,806-812,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs17221812,KCNA5,missense,DOC_PP2A_B56_1,532-538,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs200396355,BBS4,missense,DOC_PP2A_B56_1,75-81,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs12069578,MFN2,missense,DOC_PP2A_B56_1,390-395,,ELME000425,PP2A holoenzyme B56-docking site,Docking site required for the regulatory subunit B56 of PP2A for protein dephosphorylation.,([LMFYWIC]..I.E)|(L..[IVLWC].E).,0.0014581403,18,1
rs35602796,LRRK2,missense,MOD_N-GLC_1,1866-1871,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs556899786,BBS2,missense,MOD_N-GLC_1,539-544,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs144777709,MTR,missense,MOD_N-GLC_1,378-383,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs202154862,PDZD7,missense,MOD_N-GLC_1,267-272,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs375609644,CEP290,missense,MOD_N-GLC_1,1257-1262,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs181215175,USH1C,missense,MOD_N-GLC_1,18-23,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs368178632,CEP41,missense,MOD_N-GLC_1,33-38,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs574477065,MYO7A,missense,MOD_N-GLC_1,500-505,,ELME000070,N-glycosylation site,"Generic motif for N-glycosylation. It was shown that Trp, Asp, and Glu are uncommon before the Ser/Thr position. Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.",.(N)[^P][ST]..,0.005017817,156,1
rs571899254,KCNQ1,missense,MOD_CDK_SPK_2,396-401,,ELME000429,CDK Phosphorylation Site,Short version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at the [ST] +2 position.,...([ST])P[RK],0.0019287195,18,0
rs138301552,NEUROD1,missense,MOD_CDK_SPK_2,188-193,,ELME000429,CDK Phosphorylation Site,Short version of the CDK phosphorylation site which shows specificity towards a lysine/arginine residue at the [ST] +2 position.,...([ST])P[RK],0.0019287195,18,0
rs200891884,UNC13D,missense,DEG_APCC_DBOX_1,96-104,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs74315416,PROKR2,missense,DEG_APCC_DBOX_1,172-180,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs144883021,LRRK2,missense,DEG_APCC_DBOX_1,115-123,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs199975570,NOD2,missense,DEG_APCC_DBOX_1,310-318,,ELME000231,APCC-binding Destruction motifs,An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner,.R..L..[LIVM].,0.0007676973,11,0
rs150947482,FZD4,missense,LIG_SH2_GRB2,507-510,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs201996784,CPT2,missense,LIG_SH2_GRB2,617-620,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs200377566,DSP,missense,LIG_SH2_GRB2,1198-1201,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs568593066,LRRK2,missense,LIG_SH2_GRB2,442-445,,ELME000084,SH2 ligand,GRB2-like Src Homology 2 (SH2) domains binding motif.,(Y).N.,0.000478687,16,3
rs139251334,LMBRD1,missense,LIG_LIR_LC3C_4,10-13,,ELME000371,Atg8 protein family ligands,Non-canonical variant of the LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}LVV",0.0001368611,1,1
rs139251334,LMBRD1,missense,LIG_LIR_LC3C_4,8-13,,ELME000371,Atg8 protein family ligands,Non-canonical variant of the LIR motif that binds to Atg8 protein family members to mediate processes involved in autophagy.,"[EDST].{0,2}LVV",0.0001368611,1,1
rs559297418,JUP,missense,LIG_KLC1_WD_1,570-578,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs56092260,PARK2,missense,LIG_KLC1_WD_1,364-371,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs5743276,NOD2,missense,LIG_KLC1_WD_1,682-691,,ELME000408,WD' motif binding TPR of kinesin light chain,This short WD or WE motif is found in cargo proteins and mediates kinesin-1-dependent microtubule transport by binding to the KLC TPR region. ,"[LMTAFSRI][^KRG]W[DE].{3,5}[LIVMFPA]",0.0003537628,22,1
rs571102620,NOD2,missense,MOD_PIKK_1,107-113,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs148897041,MTR,missense,MOD_PIKK_1,658-664,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs200759249,KCNA5,missense,MOD_PIKK_1,384-390,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs184498773,RET,missense,MOD_PIKK_1,677-683,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs114664276,NOD2,missense,MOD_PIKK_1,680-686,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs201261098,KRT14,missense,MOD_PIKK_1,259-265,,ELME000202,PIKK phosphorylation site,(ST)Q motif which is phosphorylated by PIKK family members.,...([ST])Q..,0.0092301077,30,0
rs567776263,LAMB3,missense,LIG_SUMO_SIM_anti_2,944-950,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs17221812,KCNA5,missense,LIG_SUMO_SIM_anti_2,530-538,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs17221812,KCNA5,missense,LIG_SUMO_SIM_anti_2,531-538,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs550851372,ROM1,missense,LIG_SUMO_SIM_anti_2,32-39,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs200416179,LRP5,missense,LIG_SUMO_SIM_anti_2,437-444,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs200416179,LRP5,missense,LIG_SUMO_SIM_anti_2,438-444,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs201835496,PROKR2,missense,LIG_SUMO_SIM_anti_2,178-184,,ELME000335,SUMO interaction site,Motif for the antiparallel beta augmentation mode of non-covalent binding to SUMO protein.,"[DEST]{1,10}.{0,1}[VIL][DESTVILMA][VIL][VILM].[DEST]{0,5}",0.0023494925,17,2
rs567776263,LAMB3,missense,MOD_PK_1,941-947,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs559446180,MYO7A,missense,MOD_PK_1,933-939,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs115690781,PYGM,missense,MOD_PK_1,256-262,,ELME000065,PK Phosphorylation site,Phosphorylase kinase phosphorylation site,[RK]..(S)[VI]..,0.0009417536,1,0
rs148897041,MTR,missense,LIG_Dynein_DLC8_1,657-663,,ELME000121,Dynein (Light Chain) binding motifs,The [KR]xTQT motif interacts with the common target-accepting grooves of 8kDa Dynein Light Chain dimer.,[^P].[KR].TQT,2.26342256988e-05,9,4
rs201389731,PYGM,missense,TRG_NES_CRM1_1,422-434,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs201183584,MKKS,missense,TRG_NES_CRM1_1,391-403,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs369292514,MYO6,missense,TRG_NES_CRM1_1,713-724,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs530481219,DSP,missense,TRG_NES_CRM1_1,1357-1369,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs530481219,DSP,missense,TRG_NES_CRM1_1,1358-1369,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs199876576,MYH7B,missense,TRG_NES_CRM1_1,862-874,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs117592152,DFNB31,missense,TRG_NES_CRM1_1,862-876,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs34738426,DSP,missense,TRG_NES_CRM1_1,1765-1778,,ELME000193,NES Nuclear Export Signal,Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.,"([DEQ].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DE])|([DE].{0,1}[LIM].{2,3}[LIVMF][^P]{2,3}[LMVF].[LMIV].{0,3}[DEQ])",0.0007626138,18,3
rs143021968,COL17A1,missense,LIG_Integrin_isoDGR_1,1359-1361,,ELME000316,Integrin binding sites,NGR motif is present in proteins of extracellular matrix which upon deamidation forms a biologically active isoDGR motif that binds to various members of integrin family.,NGR,0.0001597252,8,0
rs550282961,PCDH15,missense,LIG_SH3_2,1439-1444,,ELME000006,SH3 ligand,This is the motif recognized by class II SH3 domains,P..P.[KR],0.0011112416,19,6
rs567017513,RBM20,missense,LIG_SH3_2,715-720,,ELME000006,SH3 ligand,This is the motif recognized by class II SH3 domains,P..P.[KR],0.0011112416,19,6
rs550282961,PCDH15,missense,LIG_WW_3,1441-1445,,ELME000135,WW domain ligands,WW domain of group III binding motif,.PPR.,0.0005673225,1,0
rs190416018,RBM20,missense,CLV_PCSK_PC1ET2_1,725-727,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs41494349,LRP5,missense,CLV_PCSK_PC1ET2_1,88-90,,ELME000100,PCSK cleavage site,NEC1/NEC2 cleavage site (K-R-|-X).,KR.,0.0039027683,6,0
rs147311278,PROKR2,missense,LIG_PDZ_Class_2,380-385,,ELME000091,PDZ ligands,The C-terminal class 2 PDZ-binding motif is classically represented by a pattern such as (VYF)X(VIL)*,...[VLIFY].[ACVILF]$,7.88851572129e-05,13,8
rs199961311,NPHS1,missense,LIG_PDZ_Class_2,1236-1241,,ELME000091,PDZ ligands,The C-terminal class 2 PDZ-binding motif is classically represented by a pattern such as (VYF)X(VIL)*,...[VLIFY].[ACVILF]$,7.88851572129e-05,13,8
rs199961311,NPHS1,missense,LIG_NRBOX,1235-1241,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs200396355,BBS4,missense,LIG_NRBOX,74-80,,ELME000045,Nuclear receptor box,The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.,[^P]L[^P][^P]LL[^P],0.0002627645,24,5
rs200416179,LRP5,missense,CLV_Separin_Metazoa,441-445,,ELME000331,Separase cleavage motif,"Separase cleavage site, best known in sister chromatid separation.",E[IMPVL][MLVP]R.,0.0003410442,5,0
rs200243831,GNRHR,missense,LIG_eIF4E_1,323-329,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs199858111,NOD2,missense,LIG_eIF4E_1,370-376,,ELME000317,eIF4E binding motif,Motif binding to the dorsal surface of eIF4E.,Y....L[VILMF],0.0001891275,13,0
rs553365957,UNC13D,missense,DEG_Kelch_Keap1_1,206-211,,ELME000390,KEAP1 binding degron,Motif that binds to the Kelch domain of KEAP1 with high affinity. This high affinity motif is required for the efficient recruitment of target proteins to the Cul3-based E3 ligase.,[DNS].[DES][TNS]GE,5.95038132581e-05,13,4
rs563967678,CEP290,missense,DEG_Kelch_Keap1_1,1844-1849,,ELME000390,KEAP1 binding degron,Motif that binds to the Kelch domain of KEAP1 with high affinity. This high affinity motif is required for the efficient recruitment of target proteins to the Cul3-based E3 ligase.,[DNS].[DES][TNS]GE,5.95038132581e-05,13,4
rs79887053,IL10RA,missense,LIG_CaM_IQ_9,440-456,,ELME000134,Helical calmodulin binding motifs,"Helical peptide motif responsible for Ca2+-independent binding of the CaM . The motif is manly characterized by a hydrophobic residue at position 1, a highly conserved Gln at position 2, basic charges at positions 6 and 11, and a variable Gly at position 7","[ACLIVTM][^P][^P][ILVMFCT]Q[^P][^P][^P][RK][^P]{4,5}[RKQ][^P][^P]",6.36805761296e-05,40,5
rs567017513,RBM20,missense,LIG_SH3_1,712-718,,ELME000005,SH3 ligand,This is the motif recognized by class I SH3 domains,[RKY]..P..P,0.0012369823,5,0
rs183101063,OCA2,missense,DOC_PP2B_LxvP_1,828-831,,ELME000367,Calcineurin (PP2B)-docking motif LxvP,Docking motif in calcineurin substrates that binds at the interface of the catalytic CNA and regulatory CNB subunits.,L.[LIVAPM]P,0.0022963509,8,0
rs150562946,PARK2,missense,MOD_N-GLC_2,254-256,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs116124880,LAMB3,missense,MOD_N-GLC_2,181-183,,ELME000079,N-glycosylation site,"Atipical motif for N-glycosylation site. Examples are Human CD69, which is uniquely glycosylated at typical (Asn-X-Ser/Thr) and atypical (Asn-X-Cys) motifs, beta protein C",(N)[^P]C,0.0002972992,5,0
rs143604755,LAMA1,missense,DEG_SCF_FBW7_2,1272-1278,,ELME000292,SCF ubiquitin ligase binding Phosphodegrons,The TPxxE phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..E",0.0003882233,2,0
rs61730754,PCDH15,missense,DEG_SCF_FBW7_2,565-572,,ELME000292,SCF ubiquitin ligase binding Phosphodegrons,The TPxxE phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..E",0.0003882233,2,0
rs61730754,PCDH15,missense,DEG_SCF_FBW7_2,567-572,,ELME000292,SCF ubiquitin ligase binding Phosphodegrons,The TPxxE phospho-dependent degron binds the FBW7 F box proteins of the SCF (Skp1_Cullin-Fbox) complex.,"[LIVMP].{0,2}(T)P..E",0.0003882233,2,0
rs143604755,LAMA1,missense,DOC_CKS1_1,1272-1277,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs539433580,BAAT,missense,DOC_CKS1_1,264-269,,ELME000358,Cks1 ligand,Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.,[MPVLIFWYQ].(T)P..,0.0019914638,8,1
rs556996220,PRF1,missense,LIG_SH2_PTP2,347-350,,ELME000083,SH2 ligand,SH-PTP2 and phospholipase C-gamma Src Homology 2 (SH2) domains binding motif.,(Y)[IV].[VILP],0.0002453931,1,0
rs55662069,MYO6,missense,DOC_PP1_SILK_1,843-848,,ELME000360,PP1-docking motif SILK,Protein phosphatase 1 catalytic subunit (PP1c) interacting motif that often cooperates with and is located N-terminal to the RVXF motif to dock proteins to PP1c.,.[GS]IL[KR][^DE],3.77750556097e-05,14,1
rs143399084,COL17A1,missense,DEG_ODPH_VHL_1,527-540,,ELME000248,Hydroxyproline modification in hypoxia signaling,Oxygen dependent prolyl hydroxylation motif in the unstructured region of hypoxia-inducible factor protein and bound by the VHL ligand.,"[IL]A(P).{6,8}[FLIVM].[FLIVM]",7.03776543919e-05,8,1
rs570519739,LRRK2,missense,LIG_Clathr_ClatBox_1,1749-1753,,ELME000047,Clathrin box,"Clathrin box motif found on cargo adaptor proteins, it interacts with the beta propeller structure located at the N-terminus of Clathrin heavy chain.",L[IVLMF].[IVLMF][DE],0.0003405507,18,3
rs143897176,PCDH15,missense,LIG_BIR_III_2,588-592,,ELME000287,IAP-binding motif (IBM),These IBMs are found at the N-terminal regions of caspase subunits where they mediate the inhibition of activated caspases by binding to conserved surface grooves on type III BIR domains of Inhibitor of Apoptosis Proteins (IAPs).,DA.P.,0.000351121,3,1
rs45608139,PINK1,missense,LIG_Pex14_1,152-156,,ELME000080,Pex14 ligand motif,Wxxx[FY] motifs present in N-terminal half of Pex5 bind to Pex13 and Pex14 at peroxisomal and glycosomal membranes to facilitate entrance of PTS1 cargo proteins into the organellar lumen.,W...[FY],0.000222625,27,1
rs568593066,LRRK2,missense,LIG_SH2_SRC,442-445,,ELME000081,SH2 ligand,Src-family Src Homology 2 (SH2) domains binding motif.,(Y)[QDEVAIL][DENPYHI][IPVGAHS],0.0008729371,23,1
rs567825969,ARL6,missense,LIG_Rb_LxCxE_1,144-161,,ELME000007,Rb pocket B binding ligand,Interacts with the Retinoblastoma protein,"([DEST]|^).{0,4}[LI].C.E.{1,4}[FLMIVAWPHY].{0,8}([DEST]|$)",0.0005417245,45,9
